Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Selin Seda Timur & R. Neslihan Gürsoy. (2021) The role of peptide-based therapeutics in oncotherapy. Journal of Drug Targeting 29:10, pages 1048-1062.
Read now
Read now
Articles from other publishers (33)
Yoshihiro Morimoto, Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon, Atrayee Bhattacharya, Rehan Ahmad, Yozo Suzuki, Hidekazu Takahashi & Donald W. Kufe. (2023) MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer. Cancer Letters 559, pages 216116.
Crossref
Crossref
Weiqiu Jin, Mengwei Zhang, Changzi Dong, Lei Huang & Qingquan Luo. (2022) The multifaceted role of MUC1 in tumor therapy resistance. Clinical and Experimental Medicine.
Crossref
Crossref
Nami Yamashita & Donald Kufe. (2022) Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression. International Journal of Molecular Sciences 23:15, pages 8219.
Crossref
Crossref
Aysooda Hosseinzadeh, Parnaz Merikhian, Nazanin Naseri, Mohammad Reza Eisavand & Leila Farahmand. (2022) MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell International 22:1.
Crossref
Crossref
John D. Schneible, Michael A. Daniele & Stefano Menegatti. 2021. Biopolymers for Biomedical and Biotechnological Applications. Biopolymers for Biomedical and Biotechnological Applications
265
356
.
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
201
220
.
Donald W Kufe. (2020) MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment. Carcinogenesis 41:9, pages 1173-1183.
Crossref
Crossref
Ho Seok Seo, Jiyeon Hyeon, In Hye Song & Han Hong Lee. (2020) Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology. Journal of Molecular Histology 51:2, pages 199-208.
Crossref
Crossref
Po-Chu Lee, Syue-Ting Chen, Ting-Chun Kuo, Tzu-Chi Lin, Mei-Chun Lin, John Huang, Ji-Shiang Hung, Chia-Lang Hsu, Hsueh-Fen Juan, Po-Huang Lee & Min-Chuan Huang. (2020) C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Oncogene 39:13, pages 2724-2740.
Crossref
Crossref
M. S. Syrkina & M. A. Rubtsov. (2019) MUC1 in Cancer Immunotherapy — New Hope or Phantom Menace?. Biochemistry (Moscow) 84:7, pages 773-781.
Crossref
Crossref
Ian S. Reynolds, Michael Fichtner, Deborah A. McNamara, Elaine W. Kay, Jochen H.M. Prehn & John P. Burke. (2019) Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers. Cancer and Metastasis Reviews 38:1-2, pages 237-257.
Crossref
Crossref
Masaaki Yamamoto, Caining Jin, Tsuyoshi Hata, Yota Yasumizu, Yan Zhang, Deli Hong, Takahiro Maeda, Masaaki Miyo, Masayuki Hiraki, Yozo Suzuki, Kunihiko Hinohara, Hasan Rajabi & Donald Kufe. (2019) MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells. Cancer Research 79:8, pages 2031-2041.
Crossref
Crossref
Fatma Gizem Avci, Berna Sariyar Akbulut & Elif Ozkirimli. (2018) Membrane Active Peptides and Their Biophysical Characterization. Biomolecules 8:3, pages 77.
Crossref
Crossref
Hasan Rajabi, Masayuki Hiraki & Donald Kufe. (2018) MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells. Oncogene 37:16, pages 2079-2088.
Crossref
Crossref
Milene Pereira Moreira, Letícia da Conceição Braga, Geovanni Dantas Cassali & Luciana Maria Silva. (2018) STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line. Experimental Cell Research 363:2, pages 283-290.
Crossref
Crossref
Antonella Borrelli, Anna Tornesello, Maria Tornesello & Franco Buonaguro. (2018) Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. Molecules 23:2, pages 295.
Crossref
Crossref
Wei Jin, Xiaodong Liao, Yaping Lv, Zhi Pang, Yuming Wang, Quanfu Li, Yahui Liao, Qing Ye, Guoqiang Chen, Kewen Zhao & Lei Huang. (2017) MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner. Cell Death & Disease 8:8, pages e2980-e2980.
Crossref
Crossref
Christian Garbar, Corinne Mascaux, Jérôme Giustiniani, Yacine Merrouche & Armand Bensussan. (2017) Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231. Scientific Reports 7:1.
Crossref
Crossref
Yuan-Feng Gong, Quan-Bo Zhou, Ya-Di Liao, Cong Mai, Tie-Jun Chen, Yun-Qiang Tang & Ru-Fu Chen. (2017) Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacy. Oncology Letters 13:4, pages 2198-2206.
Crossref
Crossref
Irina I. Tyuryaeva, Olga G. Lyublinskaya, Ivan S. Podkorytov & Nikolai R. Skrynnikov. (2017) Origin of anti-tumor activity of the cysteine-containing GO peptides and further optimization of their cytotoxic properties. Scientific Reports 7:1.
Crossref
Crossref
Masayuki Hiraki, Yozo Suzuki, Maroof Alam, Kunihiko Hinohara, Masanori Hasegawa, Caining Jin, Surender Kharbanda & Donald Kufe. (2016) MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors. Scientific Reports 6:1.
Crossref
Crossref
Whitney Barham, Lianyi Chen, Oleg Tikhomirov, Halina Onishko, Linda Gleaves, Thomas P. Stricker, Timothy S. Blackwell & Fiona E. Yull. (2015) Aberrant activation of NF-?B signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer 15:1.
Crossref
Crossref
Agnieszka Gornowicz, Anna Bielawska, Robert Czarnomysy, Halina Gabryel-Porowska, Anna Muszyńska & Krzysztof Bielawski. (2015) The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells. Molecular and Cellular Biochemistry 408:1-2, pages 103-113.
Crossref
Crossref
Masanori Hasegawa, Raj Kumar Sinha, Manoj Kumar, Maroof Alam, Li Yin, Deepak Raina, Akriti Kharbanda, Govind Panchamoorthy, Dikshi Gupta, Harpal Singh, Surender Kharbanda & Donald Kufe. (2015) Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation. Clinical Cancer Research 21:10, pages 2338-2347.
Crossref
Crossref
Kwong Y. Tsang, Caroline Jochems & Jeffrey Schlom. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
1
27
.
Y Hou, J Gao, H Xu, Y Xu, Z Zhang, Q Xu & C Zhang. (2013) PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability. Oncogene 33:49, pages 5619-5625.
Crossref
Crossref
Nicolas Jonckheere, Nicolas Skrypek & Isabelle Van Seuningen. (2014) Mucins and tumor resistance to chemotherapeutic drugs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 142-151.
Crossref
Crossref
Maroof Alam, Hasan Rajabi, Rehan Ahmad, Caining Jin & Donald Kufe. (2014) Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells. Oncotarget 5:9, pages 2622-2634.
Crossref
Crossref
Mindaugas Andrulis, Elena Ellert, Ulla Mandel, Henrik Clausen, Nicola Lehners, Marc-Steffen Raab, Hartmut Goldschmidt & Reinhard Schwartz-Albiez. (2014) Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localization. Histopathology 64:6, pages 799-806.
Crossref
Crossref
Caroline Jochems, Jo A. Tucker, Matteo Vergati, Benjamin Boyerinas, James L. Gulley, Jeffrey Schlom & Kwong-Yok Tsang. (2013) Identification and characterization of agonist epitopes of the MUC1-C oncoprotein. Cancer Immunology, Immunotherapy 63:2, pages 161-174.
Crossref
Crossref
Jeffrey Schlom, James W. Hodge, Claudia Palena, Kwong-Yok Tsang, Caroline Jochems, John W. Greiner, Benedetto Farsaci, Ravi A. Madan, Christopher R. Heery & James L. Gulley. 2014.
67
124
.
Caroline Jochems, Jeffrey Schlom & James L. Gulley. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development
291
327
.
Danye Zhang, Jian Gao, Liancheng Zhu, Zhenhua Hu, Rui Hou, Shuice Liu, Mingzi Tan, Juanjuan Liu & Bei Lin. (2013) Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers. International Journal of Molecular Sciences 14:6, pages 11024-11033.
Crossref
Crossref